Healthcare provider profile · identity verified

James Lee Gahimer, M.D.

Internal Medicine · GREENWOOD, IN · NPI 1144494592

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	968	268
Levothyroxine Sodium	Levothyroxine Sodium	646	171
Losartan Potassium	Losartan Potassium	541	163
Pantoprazole Sodium	Pantoprazole Sodium	484	139
Amlodipine Besylate	Amlodipine Besylate	474	146
Omeprazole	Omeprazole	415	117
Lisinopril	Lisinopril	404	104
Rosuvastatin Calcium	Rosuvastatin Calcium	337	103
Gabapentin	Gabapentin	326	115
Sertraline Hcl	Sertraline Hcl	286	84
Metformin Hcl	Metformin Hcl	262	70
Metoprolol Succinate	Metoprolol Succinate	257	71
Trazodone Hcl	Trazodone Hcl	230	82
Tamsulosin Hcl	Tamsulosin Hcl	215	60
Hydrochlorothiazide	Hydrochlorothiazide	213	59
Escitalopram Oxalate	Escitalopram Oxalate	196	52
Tramadol Hcl	Tramadol Hcl	191	83
Simvastatin	Simvastatin	185	58
Furosemide	Furosemide	179	59
Montelukast Sodium	Montelukast Sodium	179	52
Allopurinol	Allopurinol	174	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	157	68
Famotidine	Famotidine	155	51
Bupropion Xl	Bupropion Hcl	147	43
Potassium Chloride	Potassium Chloride	145	48
Metoprolol Tartrate	Metoprolol Tartrate	142	47
Pioglitazone Hcl	Pioglitazone Hcl	141	45
Duloxetine Hcl	Duloxetine Hcl	136	39
Mounjaro	Tirzepatide	135	27
Alendronate Sodium	Alendronate Sodium	134	47
Ezetimibe	Ezetimibe	134	38
Spironolactone	Spironolactone	124	35
Carvedilol	Carvedilol	113	32
Jardiance	Empagliflozin	113	28
Ozempic	Semaglutide	113	29
Albuterol Sulfate Hfa	Albuterol Sulfate	112	49
Glipizide	Glipizide	103	25
Pravastatin Sodium	Pravastatin Sodium	103	28
Eliquis	Apixaban	96	33
Torsemide	Torsemide	91	30
Clopidogrel	Clopidogrel Bisulfate	89	27
Fluticasone Propionate	Fluticasone Propionate	89	39
Metformin Hcl Er	Metformin Hcl	86	27
Fluoxetine Hcl	Fluoxetine Hcl	85	23
Valsartan	Valsartan	78	21
Finasteride	Finasteride	77	22
Citalopram Hbr	Citalopram Hydrobromide	76	18
Mirtazapine	Mirtazapine	74	22
Klor-Con M20	Potassium Chloride	72	26
Ropinirole Hcl	Ropinirole Hcl	68	19
Cephalexin	Cephalexin	67	48
Venlafaxine Hcl Er	Venlafaxine Hcl	65	15
Buspirone Hcl	Buspirone Hcl	63	16
Paroxetine Hcl	Paroxetine Hcl	62	16
Glipizide Er	Glipizide	61	20
Prednisone	Prednisone	61	31
Doxazosin Mesylate	Doxazosin Mesylate	60	15
Synthroid	Levothyroxine Sodium	57	15
Meloxicam	Meloxicam	56	18
Bupropion Hcl Sr	Bupropion Hcl	54	20
Baclofen	Baclofen	53	20
Trulicity	Dulaglutide	53	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	17
Lorazepam	Lorazepam	52	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	15
Zolpidem Tartrate	Zolpidem Tartrate	52	29
Acyclovir	Acyclovir	51	16
Memantine Hcl	Memantine Hcl	48	17
Primidone	Primidone	47	16
Alprazolam	Alprazolam	45	24
Methylprednisolone	Methylprednisolone	45	37
Clonazepam	Clonazepam	42	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	13
Ondansetron Hcl	Ondansetron Hcl	41	14
Ondansetron Odt	Ondansetron	41	19
Atenolol	Atenolol	39	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	14
Oxybutynin Chloride Er	Oxybutynin Chloride	37	13
Vitamin D2	Ergocalciferol (Vitamin D2)	36	12
Azelastine Hcl	Azelastine Hcl	34	11
Doxycycline Hyclate	Doxycycline Hyclate	34	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	13
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	11
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Ipratropium Bromide	Ipratropium Bromide	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	30	14
Xarelto	Rivaroxaban	30	suppressed
Celecoxib	Celecoxib	29	11
Diazepam	Diazepam	29	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	11
Levetiracetam	Levetiracetam	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Lamotrigine	Lamotrigine	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Methenamine Hippurate	Methenamine Hippurate	27	13
Fluconazole	Fluconazole	25	13
Nitroglycerin	Nitroglycerin	25	23
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	24	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Nystatin	Nystatin	24	17
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	11
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Pregabalin	Pregabalin	21	12
Propranolol Hcl	Propranolol Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Clonidine Hcl	Clonidine Hcl	20	suppressed
Estradiol	Estradiol	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Ramipril	Ramipril	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Klor-Con M10	Potassium Chloride	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	13
Midodrine Hcl	Midodrine Hcl	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Procto-Med Hc	Hydrocortisone	15	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Prolia	Denosumab	14	suppressed
Risperidone	Risperidone	14	suppressed
Topiramate	Topiramate	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Enbrel Sureclick	Etanercept	11	suppressed
Lagevrio (Eua)	Molnupiravir	11	11
Lansoprazole	Lansoprazole	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error